Thursday Dec 26, 2024
Thursday Dec 26, 2024
Friday, 1 April 2016 00:05 - - {{hitsCtrl.values.hits}}
From left: Singhe Hospitals Director Marketing Lakshika Weerasinghe, Singhe Hospitals Ltd. Director – Laboratories Dr. Sunil Navaratnaraja, Credence Genomics CEO/Director Dr. Vaz Gnanam and Marketing Advisor Neville Perera
Singhe Hospitals, a leader in healthcare based in Ratnapura District with close to 50 beds, is a multispecialty service healthcare provider. The hospital now provides a range of medical and surgical specialties catering to patient populations in the Sabaragamuwa Province and further has established a laboratory network to cater to the growing demand for first line diagnostics.
Singhe Hospitals will partner with Credence to deliver to both its inpatients as well as outpatients, Credence’s cutting edge diagnostic tests which can be used to predict, diagnose and treat patients with a variety of conditions.
Credence is Sri Lanka’s pioneer in offering next generation sequencing services. Being a leader in clinical genomics, Credence provides tests to diagnose infections with over 95% sensitivity and specificity in half the time. Its unique portfolio of tests also caters to predicting and diagnosing cancer especially of the breast and colorectal which are the most common forms of inherited cancers in Sri Lanka. Credence genomics also is the only organisation in Sri Lanka to offer precision medicine tests for chemotherapy used in cancer.
Singhe Hospitals Ltd. Director – Laboratories Dr. Sunil Navaratnaraja said: “Singhe Hospitals is a PLC hospital striving to expand its laboratory services to the entire country and this collaboration will further enhance our services in our endeavour to provide world class diagnostic services to Sri Lankans.”
Credence Genomics CEO/Director Dr. Vaz Gnanam said: “As genomic diagnostics comes into the forefront of healthcare diagnostics, our specialised tests help both physicians and patients alike by diagnosing with extreme accuracy. The partnership with Singhe Hospitals will cater to Singhe’s expanding patient reach and provide them with extremely accurate and cutting edge diagnostic tests.”
Singhe Hospitals PLC is a publicly traded entity who continue to maintain massive strides in the provision of healthcare services to both the private and the government sector. Through its partnerships and unique service offerings Singhe has seen considerable growth in other parts of Sri Lanka.
“It’s a great privilege to tie up with Credence laboratories at this point of time where Singhe Hospitals is expanding its wings island wide,” stated Singhe Hospitals Director Marketing Lakshika Weerasinghe.
Credence is one of the 15 laboratories world over which specialises in commercialised diagnostic services based on the next generation sequencing platform. Providing a diagnostic accuracy of over 95% and ultrafast turnaround times, Credence works with an expert panel of medical consultants from all spheres and additionally provides genetic counselling services with extreme confidentiality.
